Have a feature idea you'd love to see implemented? Let us know!

LFVN Lifevantage Corp

Price (delayed)

$12.19

Market cap

$152.12M

P/E Ratio

50.79

Dividend/share

$0.15

EPS

$0.24

Enterprise value

$148.85M

LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced ...

Highlights
LFVN's quick ratio is down by 25% year-on-year but it is up by 2.3% since the previous quarter
LFVN's EPS is up by 20% YoY but it is down by 14% QoQ
The price to earnings (P/E) is 158% more than the 5-year quarterly average of 19.7 and 90% more than the last 4 quarters average of 26.7
The company's equity fell by 25% YoY and by 2.9% QoQ

Key stats

What are the main financial stats of LFVN
Market
Shares outstanding
12.48M
Market cap
$152.12M
Enterprise value
$148.85M
Valuations
Price to earnings (P/E)
50.79
Price to book (P/B)
5.96
Price to sales (P/S)
0.76
EV/EBIT
34.22
EV/EBITDA
16.15
EV/Sales
0.74
Earnings
Revenue
$200.16M
EBIT
$4.35M
EBITDA
$9.22M
Free cash flow
$9.95M
Per share
EPS
$0.24
Free cash flow per share
$0.8
Book value per share
$2.05
Revenue per share
$16.07
TBVPS
$4.81
Balance sheet
Total assets
$60.3M
Total liabilities
$34.31M
Debt
$13.61M
Equity
$25.99M
Working capital
$15.34M
Liquidity
Debt to equity
0.52
Current ratio
1.69
Quick ratio
0.89
Net debt/EBITDA
-0.36
Margins
EBITDA margin
4.6%
Gross margin
79.3%
Net margin
1.5%
Operating margin
2.2%
Efficiency
Return on assets
4.7%
Return on equity
10.7%
Return on invested capital
12.3%
Return on capital employed
11.5%
Return on sales
2.2%
Dividend
Dividend yield
1.23%
DPS
$0.15
Payout ratio
62.5%

LFVN stock price

How has the Lifevantage stock price performed over time
Intraday
2.27%
1 week
6.09%
1 month
42.91%
1 year
66.3%
YTD
103.17%
QTD
0.91%

Financial performance

How have Lifevantage's revenue and profit performed over time
Revenue
$200.16M
Gross profit
$158.72M
Operating income
$4.33M
Net income
$2.94M
Gross margin
79.3%
Net margin
1.5%
The net margin has grown by 25% YoY but it has contracted by 17% from the previous quarter
The net income has contracted by 18% from the previous quarter but it has grown by 16% YoY
The company's operating margin rose by 10% QoQ and by 10% YoY
LFVN's operating income is up by 8% since the previous quarter

Growth

What is Lifevantage's growth rate over time

Valuation

What is Lifevantage stock price valuation
P/E
50.79
P/B
5.96
P/S
0.76
EV/EBIT
34.22
EV/EBITDA
16.15
EV/Sales
0.74
The price to earnings (P/E) is 158% more than the 5-year quarterly average of 19.7 and 90% more than the last 4 quarters average of 26.7
LFVN's EPS is up by 20% YoY but it is down by 14% QoQ
The price to book (P/B) is 106% higher than the last 4 quarters average of 2.9 and 92% higher than the 5-year quarterly average of 3.1
The company's equity fell by 25% YoY and by 2.9% QoQ
The P/S is 90% more than the last 4 quarters average of 0.4 and 52% more than the 5-year quarterly average of 0.5
The revenue has declined by 6% year-on-year and by 2.6% since the previous quarter

Efficiency

How efficient is Lifevantage business performance
LFVN's return on equity is up by 39% year-on-year but it is down by 12% since the previous quarter
The company's return on assets rose by 24% YoY but it fell by 16% QoQ
The return on invested capital is up by 23% year-on-year and by 6% since the previous quarter
LFVN's ROS is up by 16% YoY and by 10% QoQ

Dividends

What is LFVN's dividend history
DPS
$0.15
Dividend yield
1.23%
Payout ratio
62.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lifevantage financials performed over time
Lifevantage's total assets is 76% more than its total liabilities
LFVN's quick ratio is down by 25% year-on-year but it is up by 2.3% since the previous quarter
The current ratio has contracted by 25% YoY
The debt is 48% less than the equity
The company's debt to equity rose by 37% YoY
The company's equity fell by 25% YoY and by 2.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.